Breast biopsy is a test performed to remove tissue or fluid from a diseased area of the patient’s body, while the removed sample is further examined to check the presence of breast cancer. There are different types of biopsy procedures depending on the product, such as vacuum assisted biopsy (VAB), core needle biopsy (CNB), and fine needle aspiration biopsy (FNAB), recommended by the doctor based on the location, size, and other characteristics of the breast abnormality.
Asia Pacific Breast Biopsy Market was worth USD 107.15 million in 2018 and estimated to be growing at a CAGR of 11.3%, to reach USD 183.01 million by 2023.
Increase in incidence of breast cancer in women especially around the age of 40 and growth in awareness regarding breast cancer screening programs drive the market growth. Emergence of technologically advanced and minimally invasive breast biopsy devices are expected to provide opportunities in this untapped market. The restraints in this market include high cost of procedure and demand skewed towards specific gender and middle age to elderly age group, eliminating a major chunk of the population segment. The risk of infection due to improper care of breast biopsy cuts and wounds and uncertain regulatory guidelines for medical devices are likely to limit the growth of the market.
The market for Breast Biopsy is broadly categorized into product, type and guidance. By product the market is segmented into Biopsy needles, guidance systems, biopsy tables, localization wires and others. By type the market is classified into Needle breast biopsy and open surgical breast biopsy. Vacuum assisted biopsy accounts for a major portion of the revenue. By guidance the market is analysed under Mammography-Guided Stereotactic Breast Biopsy, Ultrasound-Guided Breast Biopsy , MRI-Guided Breast Biopsy , other techniques. The ultrasound segment is expected to be the fastest growing segment. On the basis of geography, the market is analysed under various regions namely China, India, Japan, Australia and South Korea. Asia Pacific is expected to grow at the highest CAGR. Its high growth can be attributed to the rise in the purchasing power of the middle class and increasing awareness about breast cancer screening.
The list of key players included in the report include Hologic Inc., Leica Biosystems Nussloch GmbH (Devicor Medical Products, Inc.), C. R. Bard, Inc., Becton and Dickinson Company, Argon Medical Devices, Cook Medical Incorporated, Encapsule medical Devices LLC., Ethicon Endo Surgery (Johnson & Johnson), Intact Medical Corporation, and Galini SRL
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Biopsy needles
5.1.3 Guidance systems
5.1.4 Biopsy tables
5.1.5 Localization wires
5.1.6 Others
5.1.7 Y-o-Y Growth Analysis, By Product
5.1.8 Market Attractiveness Analysis, By Product
5.1.9 Market Share Analysis, By Product
5.2 Type
5.2.1 Introduction
5.2.2 Needle breast biopsy
5.2.2.1 Core needle biopsy
5.2.2.2 Fine needle aspiration biopsy
5.2.2.3 Vacuum assisted biopsy
5.2.3 Open surgical breast biopsy
5.2.3.1 Excisional breast biopsy
5.2.3.2 Incisional breast biopsy
5.2.4 Y-o-Y Growth Analysis, By Type
5.2.5 Market Attractiveness Analysis, By Type
5.2.6 Market Share Analysis, By Type
5.3 Guidance
5.3.1 Introduction
5.3.2 Mammography-Guided Stereotactic Breast Biopsy
5.3.3 Ultrasound-Guided Breast Biopsy
5.3.4 MRI-Guided Breast Biopsy
5.3.5 Other Guidance Techniques
5.3.6 Y-o-Y Growth Analysis, By Application
5.3.7 Market Attractiveness Analysis, By Application
5.3.8 Market Share Analysis, By Application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Type
6.1.3.4 By Guidance
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Type
6.1.4.4 By Guidance
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Type
6.1.5.4 By Guidance
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Hologic Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Leica Biosystems Nussloch GmbH
8.3 C. R. Bard Inc.
8.4 Becton and Dickinson Company
8.5 Argon Medical Devices
8.6 Cook Medical Incorporated
8.7 Encapsule medical Devices LLC.
8.8 Ethicon Endo Surgery
8.9 Intact Medical Corporation
8.10 Galini SRL
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
